HIV molecular immunology database


Patient Detail

Patient Code VID417
Patient Sex
Risk Factor
Infection Country
Infection City
Infection Year
HLA Type A*03:01, A*30:04, B*35:01, B*50:01, C*04:01, C*06:02, DQB1*02, DQB1*05, DRB1*01:01, DRB1*07:01, DRB4
Patient Ethnicity
Species human
Patient Note Volunteer ID 417 is a healthy HIV-negative subject who was administered the first generation of HIVconsv vaccine, and whose PBMC responded to the peptides annotated above (DDDCM, where D = pSG2.HIVconsv; C = ChAdV63.HIVconsv, 5x1010 virus particles; M = MVA.HIVconsv 2x10 plaque forming units), and whose PBMC responded to the peptides annotated above with a peak EliSpot against CD4+ T cell epitopes of 4260 SFU/106 PBMC. [Borthwick2017CTL, PMID: 28448594 & Borthwick2020HTL, PMID: 31963212].
CTL CD8+ Records 61803, 61806, 61807
T-Helper CD4+ Records 201959, 201960, 201961, 201962, 201963, 201964, 201965, 201966, 201967, 201968, 201969, 201970, 201971, 201972
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health